PJP - Invesco Dynamic Pharmaceuticals ETF
|Ex-Dividend Date||Mar 22, 2021|
|Trading Day||April 19|
|Day's Range||79.17 - 79.98|
|52-Week Range||59.27 - 81.86|
The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
|Asset Class |
|Inception Date |
Jun 23, 2005
|Ticker Symbol |
|Index Tracked |
Dynamic Pharmaceutical Intellidex Index
Top 10 Holdings51.40% of assets
|Johnson & Johnson||JNJ||5.15%|
|Five Prime Therapeutics||FPRX||4.86%|
|Mar 22, 2021||$0.153||Mar 31, 2021|
|Dec 21, 2020||$0.131||Dec 31, 2020|
|Sep 21, 2020||$0.117||Sep 30, 2020|
|Jun 22, 2020||$0.156||Jun 30, 2020|
|Mar 23, 2020||$0.136||Mar 31, 2020|
|Dec 23, 2019||$0.162||Dec 31, 2019|
Robust results led to solid trading in pharma ETFs in a month.
Despite robust results, pharma ETFs have been trending downward in a month.